USP18 稳定FTO蛋白通过抑制m6A修改SIRT6激活缺血性中风中的线粒
Mingyu Song1,2,3, Fang Yi2,4, Feiyue Zeng5
1Department of Neurology, Xiangya Hospital, Central South University, Hunan Province, Changsha, 410008, People's Republic of China.
Molecular neurobiology
|February 10, 2024
概括
乌比基特异性酶18 (USP18) 通过稳定FTO蛋白,激活细胞和增强SIRT6/AMPK/PGC-1α/AKT通路来预防缺血性中风. 这种新的机制为缺血性脑损伤提供了一个有希望的治疗点.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 生物化学 生化学
背景情况:
- 缺血性中风 (IS) 是导致死亡和残疾的主要原因.
- 乌比基特异性酶18 (USP18) 显示神经保护作用,但其在IS中的调节机制尚未完全理解.
研究的目的:
- 阐明USP18减轻缺血性脑损伤的分子机制.
- 研究USP18和脂肪质量和与肥胖相关的蛋白质 (FTO) 在IS病原和潜在的治疗干预中的作用.
主要方法:
- 在体内 (MCAO) 和体内 (OGD/R) 建立的缺血性中风模型.
- 使用MTT,LDH,ROS,线粒体膜潜力和流细胞计评估神经细胞损伤.
- 通过qPCR,西式涂抹,免疫光,Co-IP,RIP和MeRIP评估分子表达;使用TEM观察到线粒菌.
主要成果:
- 在OGD/R模型中,USP18和FTO表达率下降.
- USP18过度表达增加了FTO蛋白质的稳定性通过de-ubiquitination.
- 通过YTHDF2进行FTO上调,减少了SIRT6的m6A修饰,增强SIRT6的表达,并激活AMPK/PGC-1α/AKT通路.
- 在IS模型中,USP18/FTO过度表达激活了线粒,改善了神经细胞损伤并改善了神经功能.
结论:
- USP18通过增加FTO稳定性来缓解缺血性中风,这反过来又通过AMPK/PGC-1α/AKT通路促进SIRT6介导的线粒.
- USP18代表了缺血性中风治疗的新型治疗标.
相关概念视频
Translocation of Proteins into the Mitochondria
3.1K
Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
3.1K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K


